These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 8897014)

  • 1. Autoantibodies to IA-2 not detected in NOD mice or BB rats.
    DeSilva MG; Jun HS; Yoon JW; Notkins AL; Lan MS
    Diabetologia; 1996 Oct; 39(10):1237-8. PubMed ID: 8897014
    [No Abstract]   [Full Text] [Related]  

  • 2. Autoantibodies to protein tyrosine phosphatase-like proteins in type I diabetes. Overlapping specificities to phogrin and ICA512/IA-2.
    Kawasaki E; Eisenbarth GS; Wasmeier C; Hutton JC
    Diabetes; 1996 Oct; 45(10):1344-9. PubMed ID: 8826969
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibodies to ICA512/IA-2 in rodent models of IDDM.
    Myers MA; Laks MR; Feeney SJ; Mandel TE; Koulmanda M; Bone A; Barley J; Rowley MJ; Mackay IR
    J Autoimmun; 1998 Jun; 11(3):265-72. PubMed ID: 9693975
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IA-2 (islet cell antigen 512) is the primary target of humoral autoimmunity against type 1 diabetes-associated tyrosine phosphatase autoantigens.
    Bonifacio E; Lampasona V; Bingley PJ
    J Immunol; 1998 Sep; 161(5):2648-54. PubMed ID: 9725268
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Concordance between twins for beta-cell autoimmunity.
    Leslie RD; Pyke DA
    Diabetes; 1996 Sep; 45(9):1284. PubMed ID: 8772736
    [No Abstract]   [Full Text] [Related]  

  • 6. Early development and spreading of autoantibodies to epitopes of IA-2 and their association with progression to type 1 diabetes.
    Naserke HE; Ziegler AG; Lampasona V; Bonifacio E
    J Immunol; 1998 Dec; 161(12):6963-9. PubMed ID: 9862731
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ICA512 autoantibody radioassay.
    Gianani R; Rabin DU; Verge CF; Yu L; Babu SR; Pietropaolo M; Eisenbarth GS
    Diabetes; 1995 Nov; 44(11):1340-4. PubMed ID: 7589834
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early Th1 response in unprimed nonobese diabetic mice to the tyrosine phosphatase-like insulinoma-associated protein 2, an autoantigen in type 1 diabetes.
    Trembleau S; Penna G; Gregori S; Magistrelli G; Isacchi A; Adorini L
    J Immunol; 2000 Dec; 165(12):6748-55. PubMed ID: 11120794
    [TBL] [Abstract][Full Text] [Related]  

  • 9. International Workshop on Lessons From Animal Models for Human Type 1 Diabetes: identification of insulin but not glutamic acid decarboxylase or IA-2 as specific autoantigens of humoral autoimmunity in nonobese diabetic mice.
    Bonifacio E; Atkinson M; Eisenbarth G; Serreze D; Kay TW; Lee-Chan E; Singh B
    Diabetes; 2001 Nov; 50(11):2451-8. PubMed ID: 11679421
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Does GAD have a unique role in triggering IDDM?
    Baekkeskov S; Kanaani J; Jaume JC; Kash S
    J Autoimmun; 2000 Nov; 15(3):279-86. PubMed ID: 11040068
    [No Abstract]   [Full Text] [Related]  

  • 11. The 37/40-kilodalton autoantigen in insulin-dependent diabetes mellitus is the putative tyrosine phosphatase IA-2.
    Passini N; Larigan JD; Genovese S; Appella E; Sinigaglia F; Rogge L
    Proc Natl Acad Sci U S A; 1995 Sep; 92(20):9412-6. PubMed ID: 7568143
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Islet autoantibodies in cord blood from patients who developed type 1 diabetes mellitus at 15-30 years of age.
    Elfving AM; Lindberg BA; Nyström L; Sundkvist G; Lernmark A; Ivarsson SA;
    Autoimmunity; 2003 Jun; 36(4):227-31. PubMed ID: 14563016
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cellular and molecular pathogenic mechanisms of insulin-dependent diabetes mellitus.
    Yoon JW; Jun HS
    Ann N Y Acad Sci; 2001 Apr; 928():200-11. PubMed ID: 11795511
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autoantigens IA-2 and GAD in Type I (insulin-dependent) diabetes.
    Leslie RD; Atkinson MA; Notkins AL
    Diabetologia; 1999 Jan; 42(1):3-14. PubMed ID: 10027571
    [No Abstract]   [Full Text] [Related]  

  • 15. Comments on the relation among GAD-65, IA-2 antibodies and body adiposity.
    Porte D; Seeley RJ; Woods SC; Baskin DG; Figlewicz DP; Schwartz MW
    Diabetologia; 2000 Jan; 43(1):134. PubMed ID: 10672457
    [No Abstract]   [Full Text] [Related]  

  • 16. HLA-DQ8-associated T cell responses to the diabetes autoantigen phogrin (IA-2 beta) in human prediabetes.
    Kelemen K; Gottlieb PA; Putnam AL; Davidson HW; Wegmann DR; Hutton JC
    J Immunol; 2004 Mar; 172(6):3955-62. PubMed ID: 15004204
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of the 37-kDa antigen in IDDM as a tyrosine phosphatase-like protein (phogrin) related to IA-2.
    Hawkes CJ; Wasmeier C; Christie MR; Hutton JC
    Diabetes; 1996 Sep; 45(9):1187-92. PubMed ID: 8772720
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of IA-2 with IA-2beta and with six other members of the protein tyrosine phosphatase family: recognition of antigenic determinants by IDDM sera.
    Notkins AL; Zhang B; Matsumoto Y; Lan MS
    J Autoimmun; 1997 Jun; 10(3):245-50. PubMed ID: 9218750
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proliferative responses to selected peptides of IA-2 in identical twins discordant for Type 1 diabetes.
    Schulz RM; Hawa M; Leslie RD; Sinigaglia F; Passini N; Rogge L; Picard JK; Londei M
    Diabetes Metab Res Rev; 2000; 16(3):150-6. PubMed ID: 10867713
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Growth and autoantibodies to IA-2 in children with type 1 diabetes.
    Cianfarani S; Bonfanti R; Manca Bitti ML; Chiumello G; Boscherini B
    Lancet; 2000 Oct; 356(9240):1521. PubMed ID: 11081554
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.